Month: January 2025

Radiopharmaceutical Manufacturing: A Multi-Disciplinary Endeavour for Medical Imaging and Interventional Treatment

Nuclear medicine is a medical specialty that involves the use of radionuclides or radioactive tracers in conjunction with highly specialized imaging instrumentation to detect the emissions in the body after oral, inhalation, or intravenous administration of radionuclides. A radioactive tracer is a drug that is composed of a short-lived medical isotope tightly attached to a

Subcutaneous Biologics Market Analysis: Current Trends and Future Outlook

Over the years, the incidence and prevalence of chronic diseases, such as diabetes, multiple sclerosis and rheumatoid arthritis, have increased significantly. This has led to the growing research and development towards the development of biologics for therapy purpose. These biologics are generally administered through parenteral route of administration in order to ensure maximum therapeutic benefit.

Key Trends in the Microbial CMO Market

Benefits offered by microbial manufacturing, such as low production costs and faster development timelines, have led many innovators to adopt microbial fermentation for next generation biologics, offering lucrative opportunities for microbial CMOs / CDMOs. Within microbial fermentation market, service providers presently claim to have most of the microbial production capacity, driving innovators to outsource their

Emerging Trends in Protein Expression Systems: Growth Opportunities And Future Outlook

Protein therapeutics have completely revolutionized the healthcare segment, greatly influencing the study and treatment of human diseases by conferring precise targeting ability to therapeutic modalities. Considering their vast potential, close to 50% of the top selling drugs in 2023 were protein therapeutics. Owing to the benefits of protein-based therapeutics, such as target specificity, biological compatibility,

Building Tomorrow’s Therapies Today: The Evolution of Cell Therapy Manufacturing Process

The American Society of Gene and Cell Therapy (ASGCT) defines cell therapy as a therapeutic modality that involves the administration of either normal or modified cells to patients for the treatment of various diseases. In this form of therapy, patients are injected with living and intact human cells that are deemed to be capable of